Literature DB >> 21686261

Subtle functional defects in the Arf-specific guanine nucleotide exchange factor IQSEC2 cause non-syndromic X-linked intellectual disability.

Cheryl Shoubridge1, Randall S Walikonis, Jozef Gécz, Robert J Harvey.   

Abstract

Mutations in IQSEC2, a guanine nucleotide exchange factor for the ADP-ribosylation factor (Arf) family of small GTPases have recently been shown to cause non-syndromic X-linked intellectual disability (ID), characterised by substantial limitations in intellectual functioning and adaptive behaviour. This discovery was revealed by a combination of large-scale resequencing of the X chromosome, and key functional assays that revealed a reduction, but not elimination, of IQSEC2 GEF activity for mutations affecting conserved amino acids in the IQ-like and Sec7 domains. Compromised GTP binding activity of IQSEC2 leading to reduced activation of selected Arf substrates (Arf1, Arf6) is expected to impact on cytoskeletal organization, dendritic spine morphology and synaptic organisation. This study highlights the need for further investigation of the IQSEC gene family and Arf GTPases in neuronal morphology and synaptic function, and suggests that the genes encoding the ArfGEFs IQSEC1 and IQSEC3 should be considered as candidates for screening in autosomal ID.

Entities:  

Year:  2010        PMID: 21686261      PMCID: PMC3116596          DOI: 10.4161/sgtp.1.2.13285

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  35 in total

Review 1.  Genetics of intellectual disability.

Authors:  H Hilger Ropers
Journal:  Curr Opin Genet Dev       Date:  2008-08-28       Impact factor: 5.578

2.  Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

Authors:  T Nagase; K Ishikawa; M Suyama; R Kikuno; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara
Journal:  DNA Res       Date:  1998-10-30       Impact factor: 4.458

3.  A familial cryptic subtelomeric deletion 12p with variable phenotypic effect.

Authors:  E Baker; L Hinton; D F Callen; E A Haan; A Dobbie; G R Sutherland
Journal:  Clin Genet       Date:  2002-03       Impact factor: 4.438

4.  AMPA receptor signaling through BRAG2 and Arf6 critical for long-term synaptic depression.

Authors:  Ralf Scholz; Sven Berberich; Louisa Rathgeber; Alexander Kolleker; Georg Köhr; Hans-Christian Kornau
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

5.  Attention-deficit/hyperactivity disorder (ADHD) and variable clinical expression of Aarskog-Scott syndrome due to a novel FGD1 gene mutation (R408Q).

Authors:  Alfredo Orrico; Lucia Galli; Sabrina Buoni; Giuseppe Hayek; Anna Luchetti; Stefania Lorenzini; Michele Zappella; Maria Grazia Pomponi; Vincenzo Sorrentino
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

6.  Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene.

Authors:  A Orrico; L Galli; L Faivre; J Clayton-Smith; S M Azzarello-Burri; J M Hertz; S Jacquemont; R Taurisano; I Arroyo Carrera; E Tarantino; K Devriendt; D Melis; T Thelle; U Meinhardt; V Sorrentino
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

7.  The postsynaptic density protein, IQ-ArfGEF/BRAG1, can interact with IRSp53 through its proline-rich sequence.

Authors:  Masashi Sanda; Akifumi Kamata; Osamu Katsumata; Kohji Fukunaga; Masahiko Watanabe; Hisatake Kondo; Hiroyuki Sakagami
Journal:  Brain Res       Date:  2008-12-03       Impact factor: 3.252

8.  A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.

Authors:  Vera M Kalscheuer; Luciana Musante; Cheng Fang; Kirsten Hoffmann; Celine Fuchs; Eloisa Carta; Emma Deas; Kanamarlapudi Venkateswarlu; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Leda Dalprà; Andreas Tzschach; Angelo Selicorni; Bernhard Lüscher; Hans-Hilger Ropers; Kirsten Harvey; Robert J Harvey
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

9.  Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor.

Authors:  N G Pasteris; A Cadle; L J Logie; M E Porteous; C E Schwartz; R E Stevenson; T W Glover; R S Wilroy; J L Gorski
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

10.  The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering.

Authors:  Kirsten Harvey; Ian C Duguid; Melissa J Alldred; Sarah E Beatty; Hamish Ward; Nicholas H Keep; Sue E Lingenfelter; Brian R Pearce; Johan Lundgren; Michael J Owen; Trevor G Smart; Bernhard Lüscher; Mark I Rees; Robert J Harvey
Journal:  J Neurosci       Date:  2004-06-23       Impact factor: 6.167

View more
  13 in total

1.  BRAG2/GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5).

Authors:  Radim Moravec; Kathryn K Conger; Ryan D'Souza; Anne B Allison; James E Casanova
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

Review 2.  Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms.

Authors:  Anand K Srivastava; Charles E Schwartz
Journal:  Neurosci Biobehav Rev       Date:  2014-04-04       Impact factor: 8.989

3.  Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.

Authors:  Muhammad Ansar; Hyung-Lok Chung; Ali Al-Otaibi; Mohammad Nael Elagabani; Thomas A Ravenscroft; Sohail A Paracha; Ralf Scholz; Tayseer Abdel Magid; Muhammad T Sarwar; Sayyed Fahim Shah; Azhar Ali Qaisar; Periklis Makrythanasis; Paul C Marcogliese; Erik-Jan Kamsteeg; Emilie Falconnet; Emmanuelle Ranza; Federico A Santoni; Hesham Aldhalaan; Ali Al-Asmari; Eissa Ali Faqeih; Jawad Ahmed; Hans-Christian Kornau; Hugo J Bellen; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2019-10-10       Impact factor: 11.025

4.  A 380-kb Duplication in 7p22.3 Encompassing the LFNG Gene in a Boy with Asperger Syndrome.

Authors:  A T Vulto-van Silfhout; A F M de Brouwer; N de Leeuw; C C Obihara; H G Brunner; B B A de Vries
Journal:  Mol Syndromol       Date:  2012-02-10

5.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

6.  Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability.

Authors:  Frederic Tran Mau-Them; Marjolaine Willems; Beate Albrecht; Elodie Sanchez; Jacques Puechberty; Sabine Endele; Anouck Schneider; Nathalie Ruiz Pallares; Chantal Missirian; Francois Rivier; Manon Girard; Muriel Holder; Sylvie Manouvrier; Isabelle Touitou; Genevieve Lefort; Pierre Sarda; Anne Moncla; Severine Drunat; Dagmar Wieczorek; David Genevieve
Journal:  Eur J Hum Genet       Date:  2013-05-15       Impact factor: 4.246

7.  Altered excitatory transmission onto hippocampal interneurons in the IQSEC2 mouse model of X-linked neurodevelopmental disease.

Authors:  Megha Sah; Amy N Shore; Sabrina Petri; Ayla Kanber; Mu Yang; Matthew C Weston; Wayne N Frankel
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

8.  Pharmacological modulation of AMPA receptors rescues specific impairments in social behavior associated with the A350V Iqsec2 mutation.

Authors:  Renad Jabarin; Nina Levy; Yasmin Abergel; Joshua H Berman; Amir Zag; Shai Netser; Andrew P Levy; Shlomo Wagner
Journal:  Transl Psychiatry       Date:  2021-04-22       Impact factor: 6.222

9.  NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Authors:  Vladimir Kashuba; Alexey A Dmitriev; George S Krasnov; Tatiana Pavlova; Ilya Ignatjev; Vasily V Gordiyuk; Anna V Gerashchenko; Eleonora A Braga; Surya P Yenamandra; Michael Lerman; Vera N Senchenko; Eugene Zabarovsky
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

10.  IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients.

Authors:  Cyril Mignot; Aoife C McMahon; Claire Bar; Philippe M Campeau; Claire Davidson; Julien Buratti; Caroline Nava; Marie-Line Jacquemont; Marilyn Tallot; Mathieu Milh; Patrick Edery; Pauline Marzin; Giulia Barcia; Christine Barnerias; Claude Besmond; Thierry Bienvenu; Ange-Line Bruel; Ledia Brunga; Berten Ceulemans; Christine Coubes; Ana G Cristancho; Fiona Cunningham; Marie-Bertille Dehouck; Elizabeth J Donner; Bénédicte Duban-Bedu; Christèle Dubourg; Elena Gardella; Julie Gauthier; David Geneviève; Stéphanie Gobin-Limballe; Ethan M Goldberg; Eveline Hagebeuk; Fadi F Hamdan; Miroslava Hančárová; Laurence Hubert; Christine Ioos; Shoji Ichikawa; Sandra Janssens; Hubert Journel; Anna Kaminska; Boris Keren; Marije Koopmans; Caroline Lacoste; Petra Laššuthová; Damien Lederer; Daphné Lehalle; Dragan Marjanovic; Julia Métreau; Jacques L Michaud; Kathryn Miller; Berge A Minassian; Joannella Morales; Marie-Laure Moutard; Arnold Munnich; Xilma R Ortiz-Gonzalez; Jean-Marc Pinard; Darina Prchalová; Audrey Putoux; Chloé Quelin; Alyssa R Rosen; Joelle Roume; Elsa Rossignol; Marleen E H Simon; Thomas Smol; Natasha Shur; Ivan Shelihan; Katalin Štěrbová; Emílie Vyhnálková; Catheline Vilain; Julie Soblet; Guillaume Smits; Samuel P Yang; Jasper J van der Smagt; Peter M van Hasselt; Marjan van Kempen; Sarah Weckhuysen; Ingo Helbig; Laurent Villard; Delphine Héron; Bobby Koeleman; Rikke S Møller; Gaetan Lesca; Katherine L Helbig; Rima Nabbout; Nienke E Verbeek; Christel Depienne
Journal:  Genet Med       Date:  2018-09-12       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.